Successful treatment of lung adenocarcinoma with gefitinib based on
EGFR
gene amplification
J Thorac Dis
.
2018 Nov;10(11):E779-E783.
doi: 10.21037/jtd.2018.10.55.
Authors
Chunguo Wang
1
,
Feng Xu
1
,
Jianfei Shen
1
,
Linna Zhang
2
,
Jian Zhang
1
,
Jiang Jin
1
,
Luca Ampollini
3
,
Paul van Schil
4
,
Hideharu Kimura
5
,
Francesco Grossi
6
,
Kenichi Suda
7
,
Bo Zhang
1
,
Dehua Ma
1
;
written on behalf of the AME Lung Cancer Collaborative Group
Affiliations
1
Department of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai 317000, China.
2
Department of Pathology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai 317000, China.
3
Thoracic Surgery, Department of Medicine and Surgery, University Hospital of Parma. Via Gramsci 14, 43126 Parma, Italy.
4
Department of Thoracic and Vascular Surgery, Antwerp University Hospital, Edegem, Belgium.
5
Department of Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
6
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
7
Division of Thoracic Surgery, Department of Surgery, Kinki University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Japan.
PMID:
30622811
PMCID:
PMC6297430
DOI:
10.21037/jtd.2018.10.55
No abstract available
Publication types
Case Reports